内分泌学
内科学
肿瘤坏死因子α
脂肪细胞
化学
纤溶酶原激活物抑制剂-1
胰岛素
脂肪组织
纤溶酶原激活剂
高胰岛素血症
胰岛素抵抗
生物
医学
作者
Tomohiro Sakamoto,Janet Woodcock‐Mitchell,Kousuke Marutsuka,John J. Mitchell,Burton E. Sobel,Satoshi Fujii
出处
期刊:American Journal of Physiology-cell Physiology
[American Physical Society]
日期:1999-06-01
卷期号:276 (6): C1391-C1397
被引量:109
标识
DOI:10.1152/ajpcell.1999.276.6.c1391
摘要
Obesity is associated with hyperinsulinemia and elevated concentrations of tumor necrosis factor-α (TNF-α) in adipose tissue. TNF-α has been implicated as an inducer of the synthesis of plasminogen activator inhibitor-1 (PAI-1), the primary physiological inhibitor of fibrinolysis, mediated by plasminogen activators in cultured adipocytes. To identify mechanism(s) through which TNF-α induces PAI-1, 3T3-L1 preadipocytes were differentiated into adipocytes and exposed to TNF-α for 24 h. TNF-α selectively increased the synthesis of PAI-1 without increasing activity of plasminogen activators. Both superoxide (generated by xanthine oxidase plus hypoxanthine) and hydrogen peroxide were potent inducers of PAI-1, and hydroxyl radical scavengers completely abolished the TNF-α induction of PAI-1. Exposure of adipocytes to TNF-α or insulin alone over 5 days increased PAI-1 production. These agonists exert synergistic effects. Results obtained suggest that TNF-α stimulates PAI-1 production by adipocytes, an effect potentiated by insulin, and that adipocyte generation of reactive oxygen centered radicals mediates the induction of PAI-1 production by TNF-α. Because induction of PAI-1 by TNF-α is potentiated synergistically by insulin, both agonists appear likely to contribute to the impairment of fibrinolytic system capacity typical in obese, hyperinsulinemic patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI